Publication | Closed Access
Prophylactic Intravitreal Bevacizumab for Diabetic Macular Edema (thickening) after Cataract Surgery: Prospective Randomized Study
42
Citations
22
References
2010
Year
Intravitreal administration of 1.25 mg bevacizumab at the time of cataract surgery is effective just for the short term and 6-month results are the same as the control group.
| Year | Citations | |
|---|---|---|
Page 1
Page 1